Lv6
3140 积分 2022-09-18 加入
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma A Narrative Review
5天前
已完结
Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study
5天前
已完结
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease
12天前
已完结
Risk-adaptive Therapy Guided by Dynamic ctDNA in Nasopharyngeal Carcinoma
22天前
已完结
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection
1个月前
已完结
Complete response to first-line osimertinib monotherapy in a complex epidermal growth factor receptor mutant (L833V/H835L) lung adenocarcinoma patient: a case report
1个月前
已完结
Dynamic ctDNA Monitoring Guides Early Treatment Intensification in Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemotherapy
2个月前
已完结
Preoperative liquid biopsy for optimal patient selection in metastatic colorectal cancer
2个月前
已完结
Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases
2个月前
已完结
Genomic and Clinical Predictors of Conversion in Initially Unresectable Colorectal Cancer Liver Metastases
2个月前
已完结
皖公网安备34019202002308
